|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | |||||
| Depreciation | |||||
| Amortization of intangible assets | |||||
| Goodwill impairment - Note 5 | |||||
| Amortization of deferred financing costs | |||||
| Stock-based compensation | |||||
| Deferred income taxes and other | |||||
| Convertible preferred stock received in litigation settlement - Note 16 | |||||
| Gain on sale of product line - Note 17 | |||||
| Loss on pension settlement - Note 8 | |||||
| Loss on extinguishment of debt | |||||
| Loss on equity securities - Note 12 | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Other assets | |||||
| Accounts payable and other liabilities | |||||
| Contract liabilities | |||||
| Other liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Additions to property, plant and equipment | |||||
| Capitalized software development costs | |||||
| Proceeds from sale of product line | |||||
| Proceeds from sale of marketable equity securities | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Borrowing from revolving line of credit | |||||
| Borrowing from term loans | |||||
| Repayment of revolving line of credit | |||||
| Repayment of term debt | |||||
| Payment of debt issuance costs | |||||
| Proceeds from exercise of stock options and employee stock purchase plan | |||||
| Taxes paid related to net share settlement of equity awards | |||||
| Net cash used in financing activities | |||||
| Effect of exchange rate changes on cash | |||||
| Effect of exchange rate changes on cash | |||||
| Increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| Supplemental disclosures of cash flow information: | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes, net of refunds | |||||
Loading...